Trials / Unknown
UnknownNCT04783636
To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers
A Randomized, Open-label, Single-dosing, 2x2 Crossover Phase 1 Study to Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Peptron, Inc. · Industry
- Sex
- Female
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The purpose of study is to compare the safety and pharmacokinetics of PT105 with PT105R in healthy postmenopausal female volunteers
Detailed description
The purpose of study is to confirm the safety and pharmacokinetics of PT105 in healthy postmenopausal female volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | leuprorelin acetate 3.75mg | PT105, PT105R |
Timeline
- Start date
- 2021-03-11
- Primary completion
- 2021-07-20
- Completion
- 2021-07-20
- First posted
- 2021-03-05
- Last updated
- 2021-03-17
Source: ClinicalTrials.gov record NCT04783636. Inclusion in this directory is not an endorsement.